The aim of BioEclosion is to contribute in the development of the next generation of rapid diagnostic test (RDTs) for low-resource settings to solve societal challenges. BioEclosion explore three key cross-cutting technological challenges that have been identified as bottlenecks in RDTs:
(i) the isolation of targets from complex specimens by novel solid-phase preconcentration strategies and advanced materials including magnetic peptides, magnetic molecularly-imprinted polymeric particles, magneto-actuated platforms, among others.
(ii) the enhancement of the analytical signal by the integration of novel materials
(iii) The exploration of emerging diagnostic biomarkers for the early detection of global diseases, and targets affecting food safety and environmental monitoring.
The final goal of BioEclosion is then reducing the burden of global diseases by improving the analytical performance of RDTs, as the sensitivity, specificity and analytical simplification
Company Details
- Employees
- 5
- Founded
- -
- Address
- Av. Can Domènech S/n, Cerdanyola Del Valles,barcelona 08193,spain
- jo****@****ion.com
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- bioeclosion.com
- HQ
- Cerdanyola del Valles, Barcelona
Bioeclosion Sl Questions
Bioeclosion Sl's website is bioeclosion.com
Bioeclosion Sl's LinkedIn profile is https://es.linkedin.com/company/bioeclosion-sl
Bioeclosion Sl has
5 employees.
View email and phone details for 5
employees at Bioeclosion Sl.
Bioeclosion Sl's industry is
Hospitals and Health Care
Bioeclosion Sl's top competitors are
Telomere Therapeutics,
Lotus Partners, S.l.,
Distinkt,
Nanoligent,
Arthex Biotech,
Connect Genomics Vet Global,
Ai-Sense,
Ubyko | Omnichannel Truly,
Nano1health - N1h,
Elnav.ai.
Bioeclosion Sl's support email address is jofre.ferrerdalmau@bioeclosion.com
Bioeclosion Sl's categories are Hospitals and Health Care
Bioeclosion Sl's founding year is 2016
